Back to search results

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

Abroad (travel likely)Recruiting

Conditions

Type 1 Diabetes Mellitus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Diabetes Research Institute, Miami, Florida, United States

    Contact: Study coordinator (Rodolfo Alejandro, MD) · islet@med.miami.edu · 305-243-5321
    Contact: Study coordinator (Ana M Alvarez, APRN) · axa383@med.miami.edu · 305 243-3389
    Contact: Principal Investigator (Rodolfo Alejandro, MD)
    David A Baidal, MD (Sub-investigator)
Study leads

  • Rodolfo Alejandro, MD

    Principal Investigator

    University of Miami

View source on ClinicalTrials.gov(opens in a new tab)